Clincosm LogoSign in Get a demo

Postmenopausal Osteoporosis

Showing 26 - 50 of 98
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postmenopausal Osteoporosis Trial in Shanghai (LY06006)

Recruiting
  • Postmenopausal Osteoporosis
  • Shanghai, Shanghai, China
    Shanghai Sixth People's Hospital
Sep 17, 2021

Bisphosphonate Unresponsive Patients

Completed
  • Postmenopausal Osteoporosis
  • Denosumab 60 MG/ML
  • Niğde, Turkey
    Niğde Bor FTR Education and Training hospital
Aug 31, 2021

Postmenopausal Osteoporosis Trial in Wuhan (HS-20090-2, Prolia)

Recruiting
  • Postmenopausal Osteoporosis
  • Wuhan, Hubei, China
    Huazhong University of Science and Technoogy
Aug 24, 2021

Postmenopausal Osteoporosis Trial (Zoledronic Acid Injection, Placebo)

Not yet recruiting
  • Postmenopausal Osteoporosis
  • Zoledronic Acid Injection
  • Placebo
  • (no location specified)
Jun 21, 2021

Postmenopausal Osteoporosis Trial (Pravastatin Sodium 80 MG, Placebo)

Not yet recruiting
  • Postmenopausal Osteoporosis
  • Pravastatin Sodium 80 MG
  • Placebo
  • (no location specified)
Jun 17, 2021

Postmenopausal Osteoporosis Trial in Ghent (Integrated Osteoporosis Care, Care As Usual)

Active, not recruiting
  • Postmenopausal Osteoporosis
  • Integrated Osteoporosis Care
  • Care As Usual
  • Ghent, Belgium
    Family physician doctor's offices
Apr 30, 2021

Postmenopausal Osteoporosis Trial in Gothenburg (Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475))

Active, not recruiting
  • Postmenopausal Osteoporosis
  • Lactobacillus reuteri ATCC PTA 6475 (L. reuteri 6475)
  • Gothenburg, Västra Götaland, Sweden
    Geriatric Medicine, Sahlgrenska University Hospital, Mölndal
Feb 12, 2021

Postmenopausal Osteoporosis Trial in Guangzhou (SAL001, FORSTEO)

Completed
  • Postmenopausal Osteoporosis
  • SAL001
  • FORSTEO
  • Guangzhou, Guangdong, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Feb 6, 2021

Postmenopausal Osteoporosis Trial in Boston (denosumab, teriparatide, Zoledronic acid)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 27, 2021

Postmenopausal Osteoporosis Trial in Worldwide (Romosozumab, Placebo, Denosumab)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Tucson, Arizona
  • +217 more
Dec 1, 2020

Postmenopausal Osteoporosis Trial in Worldwide (Alendronate)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Lakewood, Colorado
  • +24 more
Nov 18, 2020

Postmenopausal Osteoporosis Trial in Shanghai (Prolia®, CMAB807)

Completed
  • Postmenopausal Osteoporosis
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Oct 9, 2020

Postmenopausal Osteoporosis Trial in Lenexa (abaloparatide-sMTS)

Completed
  • Postmenopausal Osteoporosis
  • abaloparatide-sMTS
  • Lenexa, Kansas
    Pharmaceutical Research Associates, Inc
May 28, 2020

Postmenopausal Osteoporosis, Osteopenia, Jaw, Edentulous, Partially Trial in Belgium, Germany, Sweden (OsseoSpeed™)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • +2 more
  • OsseoSpeed™
  • Leuven, Belgium
  • +3 more
Nov 25, 2019

Postmenopausal Osteoporosis Trial in Shanghai (QL1206, Placebos)

Unknown status
  • Postmenopausal Osteoporosis
  • Shanghai, Shanghai, China
    Shanghai sixth people's hospital
Nov 5, 2019

Postmenopausal Osteoporosis Trial in Korea, Republic of (Romosozumab, Placebo)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Busan, Korea, Republic of
  • +9 more
Sep 23, 2019

Postmenopausal Osteoporosis Trial in Worldwide (Teriparatide, Risedronate, Placebo)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Birmingham, Alabama
  • +102 more
Sep 9, 2019

Postmenopausal Osteoporosis Trial in Athens, Thessaloniki (Denosumab, Zoledronic acid)

Completed
  • Postmenopausal Osteoporosis
  • Athens, Greece
  • +1 more
Mar 8, 2019

Postmenopausal Osteoporosis Trial in Fuzhou (osteoporosis)

Completed
  • Postmenopausal Osteoporosis
  • osteoporosis
  • Fuzhou, Fujian, China
    Fujian Institute of Trational Chiness Medicine
Feb 25, 2019

Bisphosphonates on Bone in Postmenopausal Osteoporosis

Completed
  • Postmenopausal Osteoporosis
  • Observation
  • Sheffield, South Yorks, United Kingdom
    Sheffield Teaching Hospitals NHS Foundation Trust
Feb 12, 2019

Postmenopausal Osteoporosis Trial in Czechia, Poland, United States (Romosozumab 90 mg/mL, Placebo 90 mg/mL, Romosozumab 70

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Romosozumab 90 mg/mL
  • +3 more
  • Gainesville, Georgia
  • +11 more
Oct 11, 2018

Postmenopausal Osteoporosis Trial in China (rhPTH(1-34) 28.2µg, rhPTH(1-34) 56.5µg, teriparatide acetate(Teribone™))

Unknown status
  • Postmenopausal Osteoporosis
  • rhPTH（1-34） 28.2μg
  • +2 more
  • Beijing, Beijing, China
  • +8 more
Oct 23, 2018

Postmenopausal Osteoporosis Trial (Denosumab, Midazolam)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • (no location specified)
Jul 9, 2018

Postmenopausal Osteoporosis Trial in Suzhou (Deferasirox and calcium-vitamin D3, Calcium-vitamin D3)

Unknown status
  • Postmenopausal Osteoporosis
  • Deferasirox and calcium-vitamin D3
  • Calcium-vitamin D3
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
May 13, 2018

Serum Ferritin and Bone Mineral Density With Bone Metabolism in

Unknown status
  • Postmenopausal Osteoporosis
  • Iron Metabolism Disorders
    • Suzhou, Jiagnsu, China
      Second Affiliated Hospital of Soochow University
    May 6, 2018